Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
It is a phase III trial to explore the efficacy and safety of metronomic chemotherapy with
Capecitabine versus intermittent Capecitabine as maintenance therapy following first-line
Capecitabine plus Docetaxel chemotherapy in treatment of HER2-negative metastatic breast
cancer(mBC).